RE: Re-rate......19 Oct 2020 12:04
Jaykee, yes mask alone...
RMS (AIM: RMS ) is pleased to announce that further to the announcement of 17 July 2020, it has signed a binding Share Purchase Agreement for the acquisition of 100% of the share capital of Pharm2Farm Limited ("P2F") (the "Acquisition"). Completion of the Acquisition is subject to regulatory and RMS shareholder approval. The Acquisition will be satisfied by the issue of 600,000,000 new ordinary shares of 0.01 pence each in the capital of the Company ("Consideration Shares"), equating to approximately GBP2,370,000 based on RMS's closing share price on 20 August 2020.